Figure 3.
Figure 3. Cytokine profiles of myeloma cells, normal BMDCs, and TCCM-treated BMDCs. (A) Cytokine array analysis showing the relative levels of secreted cytokines in the medium of 5TGM1, normal, and TCCM-treated BMDCs. Positive (Pos) and negative (Neg) controls were included in the array. An arbitrary unit, measured as the density of dots on a membrane for each cytokine in relationship to positive and negative controls, is provided to represent the relative concentration of the cytokines. Representative results of 2 experiments are shown. (B) RT-PCR detecting cytokine mRNA expression in 3 myeloma cell lines. Representative results of 3 experiments are shown. (C) ELISA assay detecting TGF-β1 secretion by 5TGM1 cells. Unconcentrated culture medium of the cell line was used to quantify the secreted cytokine. Results shown are the mean ± SD of 3 experiments. *P < .05; **P < .01 (compared with normal controls).

Cytokine profiles of myeloma cells, normal BMDCs, and TCCM-treated BMDCs. (A) Cytokine array analysis showing the relative levels of secreted cytokines in the medium of 5TGM1, normal, and TCCM-treated BMDCs. Positive (Pos) and negative (Neg) controls were included in the array. An arbitrary unit, measured as the density of dots on a membrane for each cytokine in relationship to positive and negative controls, is provided to represent the relative concentration of the cytokines. Representative results of 2 experiments are shown. (B) RT-PCR detecting cytokine mRNA expression in 3 myeloma cell lines. Representative results of 3 experiments are shown. (C) ELISA assay detecting TGF-β1 secretion by 5TGM1 cells. Unconcentrated culture medium of the cell line was used to quantify the secreted cytokine. Results shown are the mean ± SD of 3 experiments. *P < .05; **P < .01 (compared with normal controls).

Close Modal

or Create an Account

Close Modal
Close Modal